Received Apr 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EW0169 | IM / AR |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | EW0168 | IM / AR |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 3 | FD7218 | IM / AR |
PFIZER #1 4/25/2021 PFIZER #2 5/16/21 PFIZER #3 12/21/2021 DEVELOPED INSIDIOUS ONSET OF POST-VACCINE SYNDROME INCLUDING POST-EXERTIONAL MALAISE, LOSS OF MENTAL CLARITY, AND SUBCLINICAL VACCINE MYOPERICARDITIS. EVALATED FOR VACCINE INDUCED IMMUNODEFICIENCY SYNDROME BY SPECIALISTS. SPIKE ABS . 25,000. LATE STARTED TREATMENT WITH COLCHICINE IVM AND PROTOCOL BASE SPIKE DETOXIFICATION.
MIGRAINE HYPOTHYROIDISM
Ubrevly 1-2 daily PRN Topiramate 2 a night Xyzal 1 at night Flonase 2 sprays - each nostril a day Aimovig 1 shot, once a month Levothyroxin 75mcg .5 in morning
Keratin - Protein from feathers Environmental Severe Anaphlylaxis Trees, grass, weeds, mold, dust Environmental Moderate Sneezing, itching, runny nose, watery eyes,
EXAM, ECG, ECHOCARDIOGRAPHY, LABORATORIES